Related Experiment Video
Updated: Jun 26, 2026

09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Understanding virulence mechanisms in M. tuberculosis infection via a circuit-based simulation framework
Elebeoba May1, Andrei Leitao, Jean-Loup Faulon
1Sandia National Laboratories, Albuquerque, NM 87185 USA. eemay@sandia.gov
Summary
Understanding Mycobacterium tuberculosis persistence is key to combating tuberculosis. This study uses simulations to explore how bacterial pathways affect TB latency and reactivation, aiding new treatment development.
Area of Science:
- Systems biology
- Infectious disease research
- Computational biology
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global health issue.
- Mtb can enter a non-replicating persistent (NRP) or latent state within host tissues, complicating treatment.
- Latent TB reactivation poses a significant risk, especially in immunocompromised individuals.
Purpose of the Study:
- To develop a circuit-based computational framework for investigating Mtb latency and reactivation.
- To quantitatively understand virulence mechanisms associated with Mtb persistence.
- To identify potential targets for novel anti-TB therapies.
Main Methods:
- Utilizing BioXyce for whole-cell and multi-cellular system simulations.
- Simulating metabolic pathways critical for Mtb persistence in host immune cells.
- Applying a systems chemical biology approach to analyze biological networks.
Main Results:
- The study demonstrates a simulation framework to model Mtb's persistence mechanisms.
- Insights into how pathogenicity-associated pathways influence TB latency and reactivation are provided.
- The approach allows for the evaluation of potential anti-TB agents' efficacy on critical biological networks.
Conclusions:
- Computational simulations offer valuable insights into Mtb latency and reactivation dynamics.
- This systems chemical biology approach can guide the development of more effective TB treatments.
- Understanding Mtb persistence is crucial for reducing TB-associated fatalities.
More Related Videos
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

